CCAR1 and breast cancer: In the first instance, the cell lysates derived from MDA-MB-468 and SKBR-3 breast cancer cells were subjected to immunoprecipitation with anti-CARP-1 (α2) polyclonal antibodies [3] followed by western immunoblotting with anti-TAZ antibodies.